Latest Market News

Page 96 of 1701
Osteopore Limited has drawn down the second tranche of its redeemable convertible notes, raising A$500,000 as part of a broader A$20 million funding agreement with Advance Opportunities Fund. The funds are earmarked to support ongoing operations and future growth initiatives.
Ada Torres
Ada Torres
16 Feb 2026
Qualitas Limited reports robust interim results for the six months to December 2025, driven by strong deployment and expanding investor mandates, reaffirming its FY26 guidance.
Claire Turing
Claire Turing
16 Feb 2026
Qualitas Limited has delivered a standout first half of FY26, posting a 30% rise in normalised net profit before tax and record investment deployment, reinforcing its position in Australia’s alternative investment sector.
Claire Turing
Claire Turing
16 Feb 2026
Qualitas Limited reported a robust interim result for the six months to December 2025, with net profit rising 27% and funds under management expanding 18% to $10.9 billion. The company’s focus on real estate private credit and build-to-rent sectors underpinned strong capital deployment and fee growth.
Claire Turing
Claire Turing
16 Feb 2026
PEXA Group has announced its strategic exit from majority-owned Digital Solutions businesses, triggering a $26 million impairment and a restatement of its FY26 financial guidance. The move signals a sharper focus on core operations amid restructuring costs.
Sophie Babbage
Sophie Babbage
16 Feb 2026
Ophir High Conviction Fund reported a 6.24% increase in net assets to $765 million for the half-year ended December 2025, despite a sharp 62.7% fall in operating profit. The Fund’s portfolio performance slowed significantly, prompting no distributions during the period.
Claire Turing
Claire Turing
16 Feb 2026
Qualitas Real Estate Income Fund reported a robust 33.7% increase in net assets to over $1 billion and a 5% rise in operating profit for the half-year ended December 2025, driven by strategic capital raisings and strong portfolio management.
Victor Sage
Victor Sage
16 Feb 2026
Praemium Limited is undertaking a major restructure of its technology division following its acquisition of Technotia Laboratories, aiming to streamline operations and reduce costs while enhancing technological capabilities.
Victor Sage
Victor Sage
16 Feb 2026
Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.
Ada Torres
Ada Torres
16 Feb 2026
H&G High Conviction Limited has significantly reduced its half-year loss following asset divestment and is actively exploring strategic alternatives to enhance shareholder value amid looming ASX re-compliance requirements.
Victor Sage
Victor Sage
16 Feb 2026
Perpetual Credit Income Trust reported a robust half-year performance with a 50% jump in net assets to $802 million and an 8% rise in profit to $21 million, underpinned by a successful capital raising and steady distributions.
Claire Turing
Claire Turing
16 Feb 2026
Acumentis Group Limited reported a robust 54% increase in profit before tax for the half year ended December 2025, driven by a strategic focus on higher-margin services and targeted acquisitions. The company’s diversification strategy and recent investments position it well for resilient growth despite stable revenue.
Claire Turing
Claire Turing
16 Feb 2026